drugset / Trial / NCT00390780

Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients

NCT00390780

Phase 3 Completed 578 enrolled Valerio Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the clinical cure of miconazole Lauriad 50 mg (1x50mg) Bioadhesive buccal tablets compared with clotrimazole troches (5x10mg) after 14 days of treatment (at the test of cure visit, at Day 17-19).

Timeline

Start
2006-07
Primary completion
2007-12
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clotrimazole Unknown 10 mg
Subject Miconazole Small molecule 50 mg Other